Magenta Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
— Initiated Phase 1 study of MGTA-145 first-line mobilization therapy, enrollment on track for data presentation before end of year…
Pharmaceuticals, Biotechnology and Life Sciences
— Initiated Phase 1 study of MGTA-145 first-line mobilization therapy, enrollment on track for data presentation before end of year…
Auryxia ® Revenue Increases to $29.1 Million for Q2’FY19, Up 21% from Q2’FY18 and Up 26% from Q1’FY19; ANDA Settlement…
NYU School of Medicine will lead trials testing CBD treatment for patients with Alcohol Use Disorder and Post-Traumatic Stress Disorder…
LONDON–(BUSINESS WIRE)–#Analytics–Quantzig, a leading analytics advisory firm, has announced the completion of their new article on the role of big…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global human vaccine market is expected to post a CAGR of close to 8% during the period 2018-2022,…
KUALA LUMPUR, Malaysia & SINGAPORE–(BUSINESS WIRE)–Eli Lilly (Malaysia) Sdn Bhd Malaysia and Eli Lilly Singapore Pte Ltd, local affiliates of…
ANN ARBOR, Mich.–(BUSINESS WIRE)–$KBLB #KBLB–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces…
A significant milestone for the firm’s Canadian investment strategy TORONTO & VANCOUVER, British Columbia & MONTREAL–(BUSINESS WIRE)–Versant Ventures today announced…
Reported positive interim results from clinical trials of AVR-RD-01 investigational gene therapy in Fabry disease, including 87% substrate reduction in…
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases…